Tag: risk

As consumer interest in the best activated charcoal grows, NativePath introduces a clean-label, high-purity formula derived from coconut shells to support bloating, gas, and digestive detox.

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.

Transition Accompanies Strong Revenue Growth, Expanded Profitability, and Strengthened Balance Sheet

VANCOUVER, BC, July 08, 2025 (GLOBE NEWSWIRE) -- Carbon Done Right Developments Inc. ("Carbon Done Right" or the "Company") (TSXV: KLX) (FSE: Q1C), a leading provider of high-quality carbon credits sourced exclusively from afforestation and reforestation projects developed and owned by the Company, is pleased to announce the addition of Yang Zhou to its board of directors. The company is finalizing the recruitment of a second board member and will provide an update in the coming weeks. The goal of these new appointments is to strengthen the company’s efforts to secure new carbon projects beyond the current focus on nature based solutions and beyond the primarily tropical geographies where the company is currently active.

Yang Zhou has an interdisciplinary background in finance (CFA), business (MBA), accounting (CICPA), law (JM) and engineering. He has over 18 years of experience as a financial analyst, management consultant, academic researcher, PE fund manager, compliance officer and licensed lawyer. He has extensive experience as an analyst focused on ESG, Impact Investing and carbon markets both in Canada and the UK. He received an MBA from the Sauder School of Business and has worked as an analyst and advisor to a number of large companies in the teleco and real estate sectors. 

The Company also announces that Neil Passmore and Abayomi Akinjide will be stepping down as Directors of the Company to focus on their senior corporate activities in the UK. Neil’s decision has been driven by his need to focus on the UK regulated investment bank he runs and reduce overseas listed Board roles. He will remain actively involved as a consultant and continue to support operations in South America including the Company’s mangrove restoration project on Suriname. The Board of Directors of Carbon Done Right express their gratitude for the outstanding contributions Mr. Passmore and Mr. Akinjide have made to the board of the Company.

About Carbon Done Right

Carbon Done Right is an owner and operator of nature-based carbon assets that serves the growing demand for carbon credits from companies seeking to meet their Net Zero goals. The Company achieves this by investing in the exploration, restoration and management of terrestrial and marine systems that can either be protected to enhance the sequestration of greenhouse gases or restored from a degraded status to fully productive ecosystems. The Company’s dedication to environmental stewardship and its robust pipeline of carbon credit projects makes it a trusted partner to the largest buyers of carbon credits in the world, in the fight against climate change. Carbon Done Right deploys capital at risk under various arrangements (including cooperation, assignment, and production sharing agreements) with government engagement in various suitable jurisdictions around the world including Sierra Leone, Yucatan, Guyana and Suriname.

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases and medical countermeasures, hereby clarifies its update regarding the research study assessing Bucillamine as a potential treatment for nerve agent exposure. This study is being conducted in collaboration with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence, which is investigating pharmacological compounds, including Bucillamine, capable of mitigating nerve agent-induced brain injury.

A Bold Move in Crypto Mining

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016^® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.

-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% --

-- Company also completes expansion of its consolidated credit facilities with an additional $33 million second lien term loan with $50 million accordion to support ongoing strategic initiatives --

In this 2025 release, Ageless Shoulders expands its digital shoulder mobility system using traditional Indian club exercises to support joint flexibility, address frozen shoulder limitations, and meet rising search demand for non-surgical, at-home movement programs.